Correlation Between Alligator Bioscience and Ascelia Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alligator Bioscience and Ascelia Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alligator Bioscience and Ascelia Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alligator Bioscience AB and Ascelia Pharma AB, you can compare the effects of market volatilities on Alligator Bioscience and Ascelia Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alligator Bioscience with a short position of Ascelia Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alligator Bioscience and Ascelia Pharma.

Diversification Opportunities for Alligator Bioscience and Ascelia Pharma

-0.83
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Alligator and Ascelia is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Alligator Bioscience AB and Ascelia Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascelia Pharma AB and Alligator Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alligator Bioscience AB are associated (or correlated) with Ascelia Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascelia Pharma AB has no effect on the direction of Alligator Bioscience i.e., Alligator Bioscience and Ascelia Pharma go up and down completely randomly.

Pair Corralation between Alligator Bioscience and Ascelia Pharma

Assuming the 90 days trading horizon Alligator Bioscience AB is expected to generate 15.4 times more return on investment than Ascelia Pharma. However, Alligator Bioscience is 15.4 times more volatile than Ascelia Pharma AB. It trades about 0.13 of its potential returns per unit of risk. Ascelia Pharma AB is currently generating about 0.01 per unit of risk. If you would invest  25.00  in Alligator Bioscience AB on October 30, 2024 and sell it today you would lose (19.40) from holding Alligator Bioscience AB or give up 77.6% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy94.74%
ValuesDaily Returns

Alligator Bioscience AB  vs.  Ascelia Pharma AB

 Performance 
       Timeline  
Alligator Bioscience 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Alligator Bioscience AB are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Alligator Bioscience unveiled solid returns over the last few months and may actually be approaching a breakup point.
Ascelia Pharma AB 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ascelia Pharma AB are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain technical and fundamental indicators, Ascelia Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Alligator Bioscience and Ascelia Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alligator Bioscience and Ascelia Pharma

The main advantage of trading using opposite Alligator Bioscience and Ascelia Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alligator Bioscience position performs unexpectedly, Ascelia Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascelia Pharma will offset losses from the drop in Ascelia Pharma's long position.
The idea behind Alligator Bioscience AB and Ascelia Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital